Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

7.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cancer care under systemic shock: utilization declines and cost increases during the COVID-19 pandemic in Colombia, evidence from matched administrative cohorts.

Archives of public health = Archives belges de sante publique·2026
Same author

ISDE guidelines on the management of cT2N0 esophageal cancer.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2026
Same author

Health for all? A cost-utility evaluation of Colombia's policy to enroll Venezuelan migrants (2021-2023).

Journal of migration and health·2025
Same author

Impact of Gene Expression Classifier Testing on Adjuvant Treatment Following Radical Prostatectomy: The G-MINOR Prospective Randomized Cluster-crossover Trial.

European urology·2024
Same author

Vitamin C alleviates hyperglycemic stress in retinal pigment epithelial cells.

Molecular biology reports·2024
Same author

Early Access to Electronic Health Records May Influence the Patient Experience.

Oncology (Williston Park, N.Y.)·2023

Related Experiment Video

Updated: Dec 8, 2025

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

9.1K

Recurrent EGFR-Mutated Non-Small Cell Lung Cancer Discovered by Abnormal Mammogram: Adjuvant/Frontline Metastatic

Mehmet Sitki Copur1, Rudy Lackner2, Paul Rodriguez3

  • 1Morrison Cancer Center, Mary Lanning Healthcare, Hastings, NE.

Oncology (Williston Park, N.Y.)
|September 23, 2020
PubMed
Summary

Metastasis to the breast from extramammary cancers is rare. This case highlights a rare instance of metastatic EGFR-mutated non-small cell lung cancer (NSCLC) detected via mammography.

More Related Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.5K
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

8.3K

Related Experiment Videos

Last Updated: Dec 8, 2025

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure
09:38

Establishing Dual Resistance to EGFR-TKI and MET-TKI in Lung Adenocarcinoma Cells In Vitro with a 2-step Dose-escalation Procedure

Published on: August 11, 2017

9.1K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.5K
Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
09:38

Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib

Published on: June 26, 2019

8.3K

Area of Science:

  • Oncology
  • Radiology
  • Medical Diagnostics

Background:

  • Breast metastasis from extramammary malignancies is uncommon, with reported incidence rates between 0.4% and 1.3%.
  • Leukemia, lymphoma, and malignant melanoma are the most frequent primary sources of breast metastases.
  • Early detection and accurate diagnosis are crucial for effective cancer management.

Observation:

  • A rare case of metastatic EGFR-mutated non-small cell lung cancer (NSCLC) presenting in the breast was identified through screening mammography.
  • The patient had a history of clinical stage IIIA NSCLC, treated with neoadjuvant chemoradiation and surgery.
  • The presentation underscores the diverse metastatic potential of non-small cell lung cancer.

Findings:

  • The study details a unique presentation of non-small cell lung cancer (NSCLC) metastasizing to the breast.
  • EGFR mutation status in NSCLC influences treatment strategies and prognosis.
  • Screening mammography can play a role in identifying unexpected metastatic disease.

Implications:

  • This case expands the understanding of rare metastatic patterns in non-small cell lung cancer (NSCLC).
  • It emphasizes the importance of considering extramammary origins in breast lesions, particularly in patients with a history of cancer.
  • Discussion includes evolving management options for EGFR-mutated NSCLC, impacting adjuvant and metastatic treatment paradigms.